Jinjun Ye
Nanjing, 210009, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Efficacy and safety of concurrent chemoradiotherapy with paclitaxel-based or S-1 regimens in treating elderly patients with esophageal squamous cell carcinoma: A multi-center propensity-score matched study.
Journal: Translational oncology
Published: June 04, 2024
Efficacy, safety, and survival of neoadjuvant immunotherapy plus chemotherapy in locally advanced esophageal squamous cell carcinoma: A real-world retrospective study.
Journal: International immunopharmacology
Published: March 17, 2024
Radiotherapy with S-1 for the treatment of esophageal squamous cell carcinoma 75 years or older.
Journal: Radiation oncology (London, England)
Published: January 21, 2024
Comparison of immunochemotherapy followed by surgery or chemoradiotherapy in locally advanced esophageal squamous cell cancer.
Journal: International immunopharmacology
Published: December 25, 2023
Impact of hematological and radiation parameters on the clinical prognosis of esophageal cancer patients treated with definitive chemoradiotherapy.
Journal: American journal of cancer research
Published: May 21, 2023
Paclitaxel and cisplatin combined with concurrent involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma: a phase II clinical trial.
Journal: Radiation oncology (London, England)
Published: April 20, 2022
Development of a prognostic signature for esophageal cancer based on nine immune related genes.
Journal: BMC cancer
Published: August 06, 2020
FAK alleviates radiation-induced rectal injury by decreasing apoptosis.
Journal: Toxicology and applied pharmacology
Published: July 22, 2018
A retrospective dosimetry study of intensity-modulated radiotherapy for nasopharyngeal carcinoma: radiation-induced brainstem injury and dose-volume analysis.
Journal: Radiation oncology (London, England)
Published: July 04, 2018
Overexpression of Dishevelled-2 contributes to proliferation and migration of human esophageal squamous cell carcinoma.
Journal: Journal of molecular histology
Published: February 16, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026